Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study)

NCT04367064 is registered in ClinicalTrials.gov with Max Healthcare Insititute Limited as lead sponsor.

NCT NCT04367064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04367064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study)
Lead sponsor
Max Healthcare Insititute Limited
Phase
Observational
Overall status
Unknown status
Start date
April 25, 2020
Completion date
December 25, 2020
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid